Literature DB >> 23664710

Development of an antibody-ELISA for seroprevalence of Trypanosoma evansi in equids of North and North-western regions of India.

Rajender Kumar1, Sanjay Kumar, S K Khurana, S C Yadav.   

Abstract

The importance of Trypanosoma evansi as the etiological agent for surra is often overlooked due to difficulty in accurate diagnosis of the disease. In the present study, an antibody-ELISA was developed using whole cell lysate antigen prepared from purified trypanosomes and used for seroprevalence study of T. evansi in equids. A total of 3695 equids were surveyed and blood samples were collected from each animal during September 2009 to August 2011. Out of these, 420 serum samples were found positive for presence of antibodies against T. evansi collected from equids of six agro-climatic zones of North and North-western regions of India comprising eight states viz., Gujarat (36/479), Haryana (11/275), Himachal Pradesh (14/83), Jammu and Kashmir (32/221), Punjab (1/38), Rajasthan (90/1148), Uttarakhand (141/753), and Uttar Pradesh (65/330). The maximum seroprevalence (19.69%) for T. evansi infection was observed in equids of Uttar Pradesh state with an overall seroprevalence of 11.36% in North and North-western regions of India. The results indicated that surra is endemic in equids of North and North-western parts of India.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody-ELISA; Equids; Equine; Seroprevalence; Surra.; Trypanosoma evansi

Mesh:

Substances:

Year:  2013        PMID: 23664710     DOI: 10.1016/j.vetpar.2013.04.018

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  7 in total

1.  Molecular characterization of internal transcribed spacer 1 (ITS 1) region of different Trypanosoma evansi isolates of India.

Authors:  Souti Prasad Sarkhel; Surender Kumar Gupta; Jyoti Kaushik; Jarnail Singh; Deepak Kumar Gaur; Sanjay Kumar; Rajender Kumar
Journal:  J Parasit Dis       Date:  2016-09-29

2.  Seroprevalence and immunological characterization of Trypanosoma evansi infection in livestock of four agro-climatic zones of Himachal Pradesh, India.

Authors:  Diksha Sharma; Snehil Gupta; Khushboo Sethi; Sanjay Kumar; Rajender Kumar
Journal:  Trop Anim Health Prod       Date:  2022-01-15       Impact factor: 1.559

3.  Biocompatibility and Targeting Efficiency of Encapsulated Quinapyramine Sulfate-Loaded Chitosan-Mannitol Nanoparticles in a Rabbit Model of Surra.

Authors:  Anju Manuja; Balvinder Kumar; Rajender Kumar; Meenu Chopra; Neeraj Dilbaghi; Sandeep Kumar; Suresh C Yadav
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

4.  CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection.

Authors:  Parveen Kumar; Rakesh Kumar; Balvinder Kumar Manuja; Harisankar Singha; Anshu Sharma; Nitin Virmani; Suresh Chandra Yadav; Anju Manuja
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 5.  Trypanosoma evansi and surra: a review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspects.

Authors:  Marc Desquesnes; Alan Dargantes; De-Hua Lai; Zhao-Rong Lun; Philippe Holzmuller; Sathaporn Jittapalapong
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

6.  Systematic review and meta-analysis on the global distribution, host range, and prevalence of Trypanosoma evansi.

Authors:  Weldegebrial G Aregawi; Getahun E Agga; Reta D Abdi; Philippe Büscher
Journal:  Parasit Vectors       Date:  2019-01-31       Impact factor: 3.876

7.  The Indirect ELISA Trypanosoma evansi in Equids: Optimisation and Application to a Serological Survey including Racing Horses, in Thailand.

Authors:  Margot Camoin; Arthur Kocher; Piangjai Chalermwong; Sarawut Yangtarra; Ketsarin Kamyingkird; Sathaporn Jittapalapong; Marc Desquesnes
Journal:  Biomed Res Int       Date:  2019-12-05       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.